Hillary Stires's guest appearances

Hillary Stires

The Intersection of Cancer and Life with Emily Garnett

The Health Design Podcast

Julia Maues

BJ Miller

Mark Lewis

Cheryl Janis

Ronald Epstein

Dan Gordon

Katherine Leon

Charles Graeber

Amit Goyal

Andrew Rea

Tia Powell

John Fox

Rick Davis

David Ross

Shobha Rayapudi

OwlTail

Hillary Stires received her BS in behavioral neuroscience from Lehigh University and her PhD in endocrinology and animal biosciences from Rutgers University, and completed a postdoctoral fellowship in tumor biology at Georgetown University’s Lombardi Comprehensive Cancer Center. Her research focused on tumor development and drug resistance in breast cancer. During her postdoctoral fellowship, Hillary became passionate about improving cancer research through establishing relationships between cancer researchers and patient advocates. Hillary actively engages with the patient advocate and research communities through twitter and has talked about her work in bringing these groups together in podcasts, blog posts, and a TEDx. After her postdoc, Hillary worked as a consultant at Avalere Health where she supported clients in regulatory strategy and navigating the FDA policy environment. Hillary is now a science policy analyst at Friends of Cancer Research, an advocacy think tank based in Washington DC. At Friends, Hillary supports the development and implementation of the organization’s research and policy agenda to drive collaboration that improves cancer research and patient outcomes. She also works with Teresa's Research Foundation to support opportunities that build relationships between research scientists and patient advocates.

Hillary Stires received her BS in behavioral neuroscience from Lehigh University and her PhD in endocrinology and animal biosciences from Rutgers University, and completed a postdoctoral fellowship in tumor biology at Georgetown University’s Lombardi Comprehensive Cancer Center. Her research focused on tumor development and drug resistance in breast cancer. During her postdoctoral fellowship, Hillary became passionate about improving cancer research through establishing relationships between cancer researchers and patient advocates. Hillary actively engages with the patient advocate and research communities through twitter and has talked about her work in bringing these groups together in podcasts, blog posts, and a TEDx. After her postdoc, Hillary worked as a consultant at Avalere Health where she supported clients in regulatory strategy and navigating the FDA policy environment. Hillary is now a science policy analyst at Friends of Cancer Research, an advocacy think tank based in Washington DC. At Friends, Hillary supports the development and implementation of the organization’s research and policy agenda to drive collaboration that improves cancer research and patient outcomes. She also works with Teresa's Research Foundation to support opportunities that build relationships between research scientists and patient advocates.

Hillary Stires, science policy analyst at Friends of Cancer Research, Washington DC.

One of the things that has plagued me since the very beginning of my breast cancer diagnosis - I mean, other than the actual breast cancer, is trying to understand what breast cancer really is. How does breast cancer work? Why has it found such a willing host in my body? And what can I do about it? I’ve been trying to understand the mechanisms of my disease so that I can understand how to stay ahead of it, how to outsmart it. And I guess that is the million-dollar question. Last December, when I first experienced disease progression, I put out a desperate call on Twitter for help understanding a pathology report. I had had a bone biopsy that had shown that my previously very estrogen positive cancer - as in, my cancer fed voraciously off of estrogen - had stopped feeding off of estrogen, and instead, found a different mechanism to fuel its growth. What mechanism, though, I didn’t know. Apparently, that is a common question for researchers too, and one that there isn’t a good, or known, answer to. It’s frustrating, feeling like you can identify the question, but not being able to find out the answer. It turns out that that frustration is not only on the patient side of things, but experienced by the cancer resrarchers as well. Today, I talk to breast cancer research scientist turned breast cancer advocate Hillary Stires. When I put out my desperate plea for help understanding my pathology report on Twitter, Hillary responded to me, and became a lifeline for me, helping me understand the issues my disease faced, as well as the issues faced by researchers and clinicians treating breast cancer in general.  Hillary is a breast cancer research scientist who now works in healthcare consulting. After completing her PhD in Endocrinology and Animal Biosciences at Rutgers University, she moved to Washington DC for a postdoctoral fellowship at Georgetown University's Lombardi Comprehensive Cancer Center. While at Georgetown, Hillary began working with patient advocates and saw the impact of their experiences on her research projects. Six months into her postdoc, her best friend was diagnosed with breast cancer at the age of 28. Hillary’s experiences moved her towards a career in healthcare policy and inspired her to develop programs to connect cancer research scientists and patient advocates. Personal Website Twitter @hillstirsci Instagram @HillaryStires  NCCS Elevate Ambassadors

One of the things that has plagued me since the very beginning of my breast cancer diagnosis - I mean, other than the actual breast cancer, is trying to understand what breast cancer really is. How does breast cancer work? Why has it found such a willing host in my body? And what can I do about it? I’ve been trying to understand the mechanisms of my disease so that I can understand how to stay ahead of it, how to outsmart it. And I guess that is the million-dollar question. Last December, when I first experienced disease progression, I put out a desperate call on Twitter for help understanding a pathology report. I had had a bone biopsy that had shown that my previously very estrogen positive cancer - as in, my cancer fed voraciously off of estrogen - had stopped feeding off of estrogen, and instead, found a different mechanism to fuel its growth. What mechanism, though, I didn’t know. Apparently, that is a common question for researchers too, and one that there isn’t a good, or known, answer to. It’s frustrating, feeling like you can identify the question, but not being able to find out the answer. It turns out that that frustration is not only on the patient side of things, but experienced by the cancer resrarchers as well. Today, I talk to breast cancer research scientist turned breast cancer advocate Hillary Stires. When I put out my desperate plea for help understanding my pathology report on Twitter, Hillary responded to me, and became a lifeline for me, helping me understand the issues my disease faced, as well as the issues faced by researchers and clinicians treating breast cancer in general.  Hillary is a breast cancer research scientist who now works in healthcare consulting. After completing her PhD in Endocrinology and Animal Biosciences at Rutgers University, she moved to Washington DC for a postdoctoral fellowship at Georgetown University's Lombardi Comprehensive Cancer Center. While at Georgetown, Hillary began working with patient advocates and saw the impact of their experiences on her research projects. Six months into her postdoc, her best friend was diagnosed with breast cancer at the age of 28. Hillary’s experiences moved her towards a career in healthcare policy and inspired her to develop programs to connect cancer research scientists and patient advocates. <a href="https://hstires.wixsite.com/hillarystires" rel="nofollow" target="_blank">Personal Website</a> <a href="twitter.com/hillstirsci" rel="nofollow" target="_blank">Twitter @hillstirsci</a> <a href="instagram.com/hillarystires" rel="nofollow" target="_blank">Instagram @HillaryStires</a> <a href="https://www.canceradvocacy.org/cancer-advocacy/elevating-survivorship/elevate-ambassadors/" rel="nofollow" target="_blank"> NCCS Elevate Ambassadors</a>

Episode 26: So How Exactly are We Going to Cure Cancer? With Hillary Stires